Boehmeria nivea attenuates the development of dextran sulfate sodium-induced experimental colitis

17Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We examined the therapeutic effect of an ethanol extract derived from Boehmeria nivea (Linn.) Gaudich in a mouse model of experimental colitis. Treatment with 70% ethanol extract derived from B. nivea (EBN) at a dose of 100, 200, or 500 mg/(kg·d) improved colon shortening, body weight, the disease activity index (DAI), and histopathological score of DSS-induced colitis mice. DSS significantly increased the levels of cyclooxygenase-(COX-) 2 in colon tissue relative to that of the untreated control group. EBN administered at 100, 200, or 500 mg/(kg·d) reduced COX-2 levels in the DSS-treated mice. In addition, EBN decreased the DSS-induced secretion of the inflammatory cytokine interleukin-6 (IL-6) and chemokine monocyte chemotactic protein-1 (MCP-1). Taken together, these data suggest that B. nivea extract is effective in preventing colitis. © 2014 Eun Ju Shin et al.

Cite

CITATION STYLE

APA

Shin, E. J., Sung, M. J., Yang, H. J., Kim, M. S., & Hwang, J. T. (2014). Boehmeria nivea attenuates the development of dextran sulfate sodium-induced experimental colitis. Mediators of Inflammation, 2014. https://doi.org/10.1155/2014/231942

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free